Biotechnology - Asia-Pacific, Markets & Marketing


Popular Filters

1 to 25 of 27 results

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda


US biotech firm Seattle Genetics says it will receive milestone payments from Japan’s Takeda Pharmaceutical…

AdcetrisAsia-PacificBiotechnologyFinancialMarkets & MarketingOncologySeattle GeneticsSouth AmericaTakeda Pharmaceuticals

Fast growth forecast for South Korean pharma market

Fast growth forecast for South Korean pharma market


South Korea's pharmaceuticals market was valued at $20 billion in 2012, growing from $14.5 billion in…

Asia-PacificBiosimilarsBiotechnologyMarkets & MarketingPricingResearch

Mylan gets exclusive rights to distribute Gilead branded drugs in India

Mylan gets exclusive rights to distribute Gilead branded drugs in India


US generics major Mylan says its India-based subsidiary has been named) exclusive branded medicines business…

AmbisomeAnti-viralsAsia-PacificBiotechnologyGilead SciencesIndiaMarkets & MarketingMylan LaboratoriesStribildTruvadaViread

Lundbeck and Otsuka partner on Biotie’s nalmefene in Japan

Lundbeck and Otsuka partner on Biotie’s nalmefene in Japan


Biotie Therapies says that its partner, Lundbeck has expanded its existing alliance with Otsuka Pharmaceutical…

Asia-PacificBiotechnologyBiotie TherapiesLicensingLundbeckMarkets & MarketingnalmefeneNeurologicalSelincro

Immutep and Eddingpharm sign accord for ImmuFact IMP321 in China


French biopharma Immutep and Chinese drugmaker Eddingpharm have entered into an agreement for the development,…

Asia-PacificBiotechnologyLicensingMarkets & MarketingOncologyResearch

First in class novel biologic for psoriasis launched in India


Bangalore, India-based Biocon (BSE: 532523), Asia's premier biotechnology company, has launched its 'first…

ALZUMAbAsia-PacificBioconBiotechnologyDermatologicalsitolizumabMarkets & Marketing

Japan briefs: Daiichi Sankyo launches silodosin in China; Fujifilm Diosynth UK unit commissioned


Japanese drug major Daiichi Sankyo says that its subsidiary, Daiichi Sankyo Pharmaceutical (Beijing),…

Asia-PacificBiotechnologyDaiichi SankyoEuropeFujifilm Diosynth BiotechnologiesMarkets & MarketingPharmaceuticalProductionsilodosinUrief

Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar


USA-based generic drugmaker Mylan (Nasdaq: MYL) says that it has delivered, through its South African-based…

AmgenAnti-Arthritics/RheumaticsAnti-viralsAsia-PacificBiotechnologyCiplaEnbrelEtaceptGenericsMarkets & MarketingMylan LaboratoriesPfizerRest of the World

Roche teams up with Ascletis on hep C treatments for China


Roche (ROG: SIX) has entered a collaboration with Ascletis Pharmaceuticals, a USA- and China-based biotech…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologydanoprevirLicensingMarkets & MarketingPharmaceuticalResearchRoche

Consultation opens for Australian code of best practice for life science companies


Trade group AusBiotech and the Australian Securities Exchange (ASX), with the support of the Victorian…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

Indian Pharma growth outpaces rivals, but must embrace innovation


Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

Indian pharmaceuticals market led by Ranbaxy in terms of revenue


The Indian pharmaceutical market is the world's third-largest in terms of volume and stands 14th in terms…

Asia-PacificBioconBiotechnologyGenericsMarkets & MarketingPanacea BiotecPharmaceuticalRanbaxy LaboratoriesSerum Institute of India

Australia's pharma sector a net importer but also one of its largest high-tech exporters


The pharmaceutical product manufacturing industry in Australia is dominated by major global pharmaceutical…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProduction

Nexavar use in Chinese patients nearly doubled in 2012


Use of Nexavar (sorafenib, from Bayer [BAYN: DE] and Onyx Pharmaceuticals) has nearly doubled in first-line…

AlimtaAsia-PacificBayerBiotechnologyEli LillyMarkets & MarketingNexavarOncologyPharmaceutical

Uptake of Peg-IFN agents for HCV in China and South Korea hindered by relatively high cost and their partial reimbursement status


Although pegylated interferon (peg-IFN; Roche's Pegasys, Merck & Co's PegIntron) combined with ribavirin…

Anti-viralsAsia-PacificBiotechnologyIncivekMarkets & MarketingMerck & CoPegasysPegIntronPharmaceuticalRocheVictrelis

Biological launches Japanese Encephalitis vaccine JEEV in India


Austria's Intercell AG (VSE: ICLL) that its partner, the Indian vaccines and pharma company Biological…

Asia-PacificBiological E LtdBiotechnologyIntercellJEEVMarkets & MarketingPharmaceuticalVaccines

Cancer treatments top breakthrough medicines list, Australian study finds


A cure for cancer is still to be found but more new treatments have been approved for Australians with…

Asia-PacificBiotechnologyHealthcareMarkets & MarketingPharmaceuticalResearch

Pharmaceutical supply chain in Japan sees squeezed margins


Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

Australia's Greens want end to Big Pharma inducements


Ahead of an announcement by pharma trade group Medicines Australia on a new Code of Conduct this week,…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

CSL Biotherapies indentifies likely reason for Fluvax problems


Australia's largest biotech firm CSL Biotherapies, a division of CSL Limited (ASX: CSL) today presented…

Asia-PacificBiotechnologyCSL BiotherapiesCSL LimitedFluvaxMarkets & MarketingVaccines

Business in Japan versus to Japan, by P Reed Maurer


A pharmaceutical company without a presence in Japan but with a hot new product ready for Phase III clinical…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

Erythropoietin market in Japan to reach $1.54 billion by 2015


The erythropoietin market in Japan is forecast to reach $1.54 billion by 2015 by analysts at TechNavio.…

Asia-PacificBiotechnologyGenericsMarkets & MarketingNephrology and HepatologyPatents

Contract manufacturing in India and China backed by government policies


Contract Manufacturing Organizations (CMO) will reap the rewards as pharmaceutical production becomes…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceutical

1 to 25 of 27 results

Back to top